Incannex Healthcare IXHL
NASDAQ IXHL
$3.35 -0.09 (-2.62%)
At close: Aug 20, 2026 · 10:43 AM UTC

Incannex Healthcare (IXHL) Other Operating Expenses (2024)

Incannex Healthcare (IXHL) posted Other Operating Expenses of -$1.1 million for Q4 2024.

Incannex Healthcare (IXHL) Other Operating Expenses (2024) Analysis & Trends

Incannex Healthcare has reported Other Operating Expenses for 1 years, with the latest figure at -$1.1 million in Q4 2024.

  • Quarterly Other Operating Expenses changed N/A year-over-year to -$1.1 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$1.1 million (changed N/A YoY) and the FY2025 annual result came in at -$932000.0, down 13.24% from the prior year.
  • Other Operating Expenses held at -$1.1 million in Q4 2024 per IXHL's latest filing.
  • Over five years, Other Operating Expenses peaked at -$1.1 million in Q4 2024 and troughed at -$1.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.76 Bn 42.79 Bn -
2 Teva Pharmaceutical Industries 43.38 Bn 39.73 Bn 2.15 Bn
3 Zoetis 31.61 Bn 29.93 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.64 Bn 22.84 Bn 5.10 Bn
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn
6 Viatris 18.82 Bn 17.93 Bn 1.46 Bn
7 Neurocrine Biosciences 15.67 Bn 15.28 Bn 935.80 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn -
10 Incannex Healthcare 41.37 Mn 41.37 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.10 Mn